ATF5 and breast cancer: Tretinoin (ranked 15) and genistein (ranked 16) as known inducers of differentiation of HL60 cells also downregulate MYC. ATF5 is widely expressed in carcinomas and has previously been shown to be a selective target for breast cancer treatment46.